miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling

被引:86
|
作者
Ma, Donglai [1 ]
Tao, Xuanchen [1 ]
Gao, Feng [1 ]
Fan, Chengjuan [1 ]
Wu, Dequan [1 ]
机构
[1] Harbin Med Univ, Dept Gen Surg, Affliated Hosp 2, Harbin 150086, Heilongjiang, Peoples R China
基金
中国博士后科学基金;
关键词
miR-224; hepatocellular carcinoma; PPP2R1B; AKT signaling; MICRORNA EXPRESSION; MIGRATION; INVASION; PTEN; GENE;
D O I
10.3892/ol.2012.742
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
microRNAs (miRNAs) are a class of small non-coding RNAs that post-transcriptionally regulate gene expression. Increasing evidence has shown that the deregulation of miRNAs is linked to cancer. The overexpression of miR-224 has been reported in several human cancers. The aim of the present study was to investigate the function of miR-224 in the pathogenetic process of hepatocellular carcinoma (HCC), and the precise mechanism underlying its function. Both gain-of-function and loss-of function assays were conducted through transfection with miR-224 mimics and miR-224 inhibitors in the HepG2 liver carcinoma cell line. The data revealed that miR-224 exerts a significant role in promoting cell proliferation, migration and invasion. Western blot analysis showed that the phosphorylation levels of AKT positively correlated with endogenous levels of miR-224. In addition, results from a dual luciferase reporter assay showed that the expression of the serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (PPP2R1B) is inhibited by miR-224; thus, it appears that PPP2R1B is a candidate target of miR-224 in HCC. These data suggest that miR-224 plays a significant role in HCC, possibly through the activation of the AKT signaling pathway by targeting PPP2R1B.
引用
收藏
页码:483 / 488
页数:6
相关论文
共 50 条
  • [21] Limonin provokes hepatocellular carcinoma cells with stemness entry into cycle via activating PI3K/Akt signaling
    Tang, Zhenyong
    Tang, Yuntian
    Li, Lei
    Liu, Tianqi
    Yang, Jianrong
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [22] TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway
    Guosheng Tan
    Binhui Xie
    Na Yu
    Jianwen Huang
    Bing Zhang
    Fangzeng Lin
    Heping Li
    International Journal of Clinical Oncology, 2021, 26 : 532 - 542
  • [23] Sortilin 1 regulates hepatocellular carcinoma progression by activating the PI3K/AKT signaling
    Ye, S.
    Wang, B.
    Zhou, Y.
    Sun, Q.
    Yang, X.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [24] ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling
    Xie, Binhui
    Zen, Qinshan
    Wang, Xiaonong
    He, Xiao
    Xie, Yuankang
    Zhang, Zixiang
    Li, Heping
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (05) : 2057 - 2066
  • [25] Loss of PR55α promotes proliferation and metastasis by activating MAPK/AKT signaling in hepatocellular carcinoma
    JiangSheng Zhao
    GuoFeng Chen
    Jingqi Li
    Shiqi Liu
    Quan Jin
    ZhengWei Zhang
    Fuzhen Qi
    JianHuai Zhang
    JianBo Xu
    Cancer Cell International, 21
  • [26] Loss of PR55α promotes proliferation and metastasis by activating MAPK/AKT signaling in hepatocellular carcinoma
    Zhao, JiangSheng
    Chen, GuoFeng
    Li, Jingqi
    Liu, Shiqi
    Jin, Quan
    Zhang, ZhengWei
    Qi, Fuzhen
    Zhang, JianHuai
    Xu, JianBo
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [27] TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway
    Tan, Guosheng
    Xie, Binhui
    Yu, Na
    Huang, Jianwen
    Zhang, Bing
    Lin, Fangzeng
    Li, Heping
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (03) : 532 - 542
  • [28] MicroRNA profile in chronic hepatitis B-related hepatocellular carcinoma (HCC): Overexpression of miR-224 in HCC tissue predicts recurrence after curative resection
    Lee, Sun Jae
    Ko, Eun Jung
    Yeon, Jong Eun
    Yoo, Yang Jae
    Kang, Keunhee
    Yoon, Eileen L.
    Suh, Sang Jun
    Lee, Hyun Jung
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yim, Hyung Joon
    Byun, Kwan Soo
    HEPATOLOGY, 2013, 58 : 1073A - 1074A
  • [29] LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
    Weidong Li
    Xuesong Dong
    Changjun He
    Gang Tan
    Ziyi Li
    Bo Zhai
    Jing Feng
    Xian Jiang
    Chang Liu
    Hongchi Jiang
    Xueying Sun
    Journal of Experimental & Clinical Cancer Research, 38
  • [30] LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
    Li, Weidong
    Dong, Xuesong
    He, Changjun
    Tan, Gang
    Li, Ziyi
    Zhai, Bo
    Feng, Jing
    Jiang, Xian
    Liu, Chang
    Jiang, Hongchi
    Sun, Xueying
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)